Efficacy and safety of three regimens based on tobramycin, dexamethasone and diclofenac for the prevention of pseudophakic macular edema. Randomized clinical trial

Fundació Parc Taulí0 个研究点开始时间: 2017年4月18日最近更新: 2017年5月22日

试验速览

暂无简介。

•1. Patients between 35-85 years
•2. Patients with cataract in any of their forms that are submitted to intervention under phacoemulsification and intraocular lens implantation.
•3. Patients who give their informed consent to participate in the study.
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 100
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range 110

•1. Diabetic patients.
•2. Patients with known previous macular pathology.
•3. Patients with previous eye surgery in the eye to intervene.
•4. Patients with cystic macular edema prior to surgery.
•5. Pregnant or lactating women.
•6. Patients unable to administer the treatment correctly.
•7. Patients with any contraindication to the study treatments according to the approved technical data sheets.
•8. Any circumstance that at the discretion of the physician may pose a risk or clinical harm to the patient's participation in the study or interfere with the assessments of the same.

发起方

Fundació Parc Taulí